Gene Query: LRRC40

Dataset Description Geneva Score
Human cell line and subcutaneous tumor 17.7
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 16.73
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 15.27
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 14.84
Hepatitis C virus functionally sequesters miR-122 14.54
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 14.54
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 14.39
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 13.53
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 13.4
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 13.11
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 13.11
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 12.91
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 12.16
RNAseq Study in CC-671 Treated Cal-51 Cells 12.0
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 11.69
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 11.33
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 11.25
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 11.25
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 11.22
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 11.11
TOP2B disturbed the quality of human oocytes with advanced maternal age 10.98
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 10.94
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 10.6
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 10.4
A transcriptome-wide divergence in protein translation scales with LIN28B expression 10.35
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 10.18
MOF acetyl transferase regulates transcription and respiration in mitochondria 10.08
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 9.82
Lysine benzoylation is a novel histone mark 9.65
Lysine benzoylation is a novel histone mark [RNA-seq] 9.65
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 9.59
Gene expression changes due to PARP knockdown in human cells 9.17
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 9.15
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 8.75
Biological effect of chronic mistranslation in mammalian cells 8.63
Effect of PRDM11 depletion in U2932 cells 8.17
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 8.12
Knockdown of ADNP in HCT116 colon cancer cells 8.07
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 8.03
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 7.96
Regulation of protein translation during mitosis 7.77
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 7.59
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 7.51
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 7.47
HNRNPL and its RNA Targets in Prostate Cancer 7.47
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 7.46
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 7.21
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 7.19
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 7.01
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 6.92
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 6.92
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 6.84
Tracking distinct RNA populations using efficient and reversible covalent chemistry 6.81
Identification of transcription start sites for human A549 cell line using ReCappable-seq 6.68
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 6.64
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 6.58
ETV7 and interferon response 6.58
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 6.53
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 6.48
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 6.45
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 6.41
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 6.41
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 6.4
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 6.34
mRNA expression profile of Lymphocytes 6.3
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 6.25
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 6.17
Global transcriptome analysis of HAP1 cells 6.16
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 6.06
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 6.05
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 6.05
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 6.05
3’ Uridylation Expands miRNA Target Repertoire 6.02
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 5.8
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 5.8
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 5.76
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 5.7
LncRNA expression profiling of ischemic stroke patients 5.7
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.64
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 5.63
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 5.63
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 5.59
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 5.58
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 5.56
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 5.54
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 5.53
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 5.51
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 5.45
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.43
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 5.37
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 5.37
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 5.34
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 5.33
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 5.33
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 5.31
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 5.29
High-throughput sequencing of PROMPT-enriched samples. 5.2
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.2
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 5.14
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 5.12
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 5.1
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 5.08
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 5.08
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 5.07
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 5.03
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 5.03
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 4.97
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 4.96
6mer seed toxicity in tumour suppressive microRNAs 4.95
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 4.88
Transcriptional landscape changes during human embryonic stem cell derivation 4.87
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 4.85
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 4.85
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 4.82
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 4.73
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 4.69
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 4.68
Transcriptome analysis of U87 cells upon LINC00152 knockdown 4.61
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 4.61
single cell RNA-seq from GM12878 (ENCSR673UIY) 4.61
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 4.58
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 4.54
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 4.53
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 4.51
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 4.49
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 4.49
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 4.47
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 4.44
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 4.42
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 4.39
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.38
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 4.34
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 4.34
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 4.31
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 4.29
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 4.28
The contribution of Alu exons to the human proteome 4.26
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 4.25
Gene expression changes after LOC550643 silencing 4.25
The Genetic Landscape of Diamond-Blackfan Anemia 4.24
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 4.22
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 4.2
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 4.17
Genes significantly down or Up-regulated upon RNF219 knockdown 4.16
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.16
Gene expression changes in human melanoma cell lines compared to primary melanocytes 4.13
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 4.11
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 4.08
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.06
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 4.04
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.04
Global Mapping of Human RNA-RNA Interactions 4.02
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 3.96
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 3.93
A Unique Epigenomic Landscape Defines Human Erythropoiesis 3.91
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 3.91
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 3.87
Global analysis of alternative splicing regulated by RBM10 3.81
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 3.8
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 3.8
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 3.79
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 3.78
RNAseq of HEK293 cells after Chtop knockdown 3.76
Co-transcriptional loading of RNA export factors shapes the human transcriptome 3.76
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 3.75
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.74
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 3.73
WRN knockout effects upon gene expression in SW48 and OVK18 3.72
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 3.71
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 3.71
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 3.69
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 3.68
Integrin signaling regulates YAP/TAZ to control skin homeostasis 3.67
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 3.65
Effect of PBK knockdown on C4-2 cell transcriptome 3.64
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 3.63
RNA expression analysis upon JMJD1C depletion 3.63
TGF-β regulation of miRNA expression in pancreatic cancer 3.62
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 3.61
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 3.59
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 3.59
Genome-wide discovery of human splicing branchpoints 3.58
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 3.58
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 3.57
TCF7L1 knockdown in pancreatic cancer 3.56
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 3.55
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 3.54
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 3.53
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 3.5
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 3.48
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.47
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 3.46
Transcriptome sequencing of K-562 cells 3.44
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 3.42
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 3.41
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 3.39
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 3.38
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 3.37
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 3.34
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 3.34
Regulation of poly(A) tail and translation during the somatic cell cycle 3.33
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 3.32
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.31
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.31
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 3.3
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 3.29
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 3.27
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 3.26
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 3.25
Determination of tRNA aminoacylation levels by high throughput sequencing 3.24
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 3.18
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.18
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 3.18
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 3.16
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 3.15
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 3.13
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.12
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 3.12
Developmental stage specific chromosome architecture in human erythroid cells 3.12
HEK293 TFAM Knockout Expression Study 3.05
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 3.05
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 3.05
MYC dependent mRNA translation shapes gene expression and cell biology 3.05
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 3.05
SRSF2 mutations impair hematopoiesis and alter exon recognition 3.04
NHLRC1 re-expression in cancer cells 3.04
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 3.03
Effect of ILF3 on translation during homeostasis and the antiviral response 3.01
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 3.01
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 3.01
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 3.0
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 3.0
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 2.99
Transcriptomic analysis of LSD1 2.97
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.97
RNA-seq analysis of differentiating human erythroblasts 2.96
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 2.94
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 2.94
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.89
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 2.89
Chromatin-informed inference of transcriptional programs in gynecologic cancers 2.89
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 2.88
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 2.86
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 2.84
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 2.84
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 2.82
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 2.81
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 2.81
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 2.8
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 2.77
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 2.77
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 2.76
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.76
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 2.75
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.71
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 2.7
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 2.7
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 2.69
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 2.69
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 2.67
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 2.65
Landscape and variation of RNA secondary structure across the human transcriptome 2.63
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 2.58
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 2.57
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 2.57
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 2.57
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.55
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 2.53
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 2.53
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.52
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.51
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.51
Effect of Hotair overexpression in human breast cancer cell lines 2.48
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.47
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 2.45
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 2.45
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 2.45
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 2.4
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.39
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.35
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 2.33
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.31
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 2.3
ARID1A and ARID1B loss in HCT116 and TOV21G cells 2.29
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 2.29
Gene expression signatures of innate lymphoid cells from human blood 2.28
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.28
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 2.27
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 2.27
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 2.26
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 2.25
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 2.24
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 2.24
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 2.23
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 2.21
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.21
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.21
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.19
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 2.18
The cohesin release factor WAPL restricts chromatin loop extension. 2.18
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 2.18
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 2.18
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 2.16
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.16
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 2.15
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 2.13
LIN28A Over-expression RNAseq 2.12
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 2.1
Downregulation of DDX5/DDX17 and REST 2.03
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 2.0
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.0
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 1.99
EWS-Fli and LNC regulated genes in comparison to GFP samples 1.99
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.98
RNA sequencing of primary human platelets and in vitro cell lines 1.96
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 1.92
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 1.92
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 1.91
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.91
Induced DNA demethylation, genome instability and transcription 1.91
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 1.89
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 1.89
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 1.86
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 1.86
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.85
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.85
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.84
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 1.82
Tracking of dCas9-methyltransferase footprints 1.81
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.78
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 1.77
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 1.76
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.73
K562 polyA RNA-Seq 1.71
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.68
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.67
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.67
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 1.66
Total RNA-seq in ALL-SIL upon TLX1 knockdown 1.66
Cajal bodies are linked to genome conformation 1.64
Cajal bodies are linked to genome conformation [RNA-Seq] 1.64
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.64
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.64
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.63
Mapping interactions for the TNIP2 hub protein 1.6
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.59
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.59
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 1.59
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.58
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.58
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.58
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.57
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 1.54
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 1.54
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.52
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.52
O-glcnAc reprograms cellular energetics 1.51
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 1.48
FBXW7 modulates stress response by post-translational modification of HSF1 1.47
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 1.47
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.47
Real-time observation of light-controlled transcription in living cells 1.46
Global transcriptome analysis of WT versus HEB-/- hESCs 1.44
The MEF2B Regulatory Network 1.42
The MEF2B Regulatory Network - RNA-seq data 1.42
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 1.4
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.37
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 1.36
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 1.36
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.35
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 1.34
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.34
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.34
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 1.32
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 1.3
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 1.28
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 1.28
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 1.27
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 1.25
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 1.25
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 1.25
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.25
PRDM1 inhibits proliferation of human colon cancer organoids 1.24
EWSR1 influences alternative splicing through direct and indirect mechanisms 1.22
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 1.19
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 1.18
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.18
Systematic discovery of endogenous human ribonucleoprotein complexes 1.17
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.14
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.1
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.1
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 1.09
SRSF1 role in cellular gene expression and splicing 1.08
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.07
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 1.07
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 1.06
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 1.06
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 1.06
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 1.05
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.03
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.99
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.99
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.98
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.98
Role of FGFR1 in neuronal devlopment 0.96
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 0.95
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.93
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.93
RNA-seq analysis of control and Myc-induced U2OS cells 0.91
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 0.9
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.9
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 0.89
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.88
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.88
Human Treg IFNg/IL-10 subpopulations 0.87
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 0.85
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 0.82
Identification of a LIF-responsive replication-competent human β cell 0.82
Transcriptome-wide modulation of splicing by the exon junction complex 0.8
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 0.79
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.77
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.73
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.72
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.71
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 0.7
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.7
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 0.7
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 0.69
HBEC-shp53-PCHD7 0.67
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 0.67
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.66
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.66
BACH2 in human plasma cell fate decision 0.64
Genome-wide analysis of the Integrator complex (HTS) 0.63
Genome-wide analysis of the Integrator complex 0.63
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 0.62
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 0.62
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.62
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.61
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.6
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.54
RNA-Seq of PRMT1 overexpression ECA109 cells 0.53
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.53
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.52
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.5
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.49
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 0.49
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.48
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 0.47
Human Treg IL-12 stimulation 0.44
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 0.44
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.4
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.4
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.39
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.39
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.38
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.37
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.37
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.35
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.35
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.35
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.33
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.33
Direct Isolation and Characterization of Human Nephron Progenitors. 0.32
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.29
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 0.29
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.28
RNA seq comparison between scrambled and shGRP78 cells 0.27
Human HAP1 cells before and after nutrient deprivation 0.26
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 0.26
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.25
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 0.24
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 0.24
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.24
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.22
Epigenomic conservation of transposable element silencing 0.21
Epigenomic conservation of transposable element silencing [RNA-seq] 0.21
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.21
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.2
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.2
The bromodomain protein BRD4 regulates splicing during heat shock 0.19
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.18
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.18
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.17
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.16
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.15
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.15
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.13
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.13
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.1
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.1
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.1
High-resolution comparative analysis of great ape genomes 0.09
Modulation of nonsense-mediated decay by rapamycin 0.09
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 0.06
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.05
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.04
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.03
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.01
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation